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Introduction
Strongyloides stercoralis is a human intestinal nematode
that is considered a common parasitic disease in tropical
and subtropical areas. It is endemic in Southeast Asia,
Africa, the West Indies, South America, Bangladesh,
and Pakistan.1 Most patients become chronically in-
fected with S. stercoralis but remain asymptomatic.
Hyperinfection syndrome with S. stercoralis describes
the syndrome of accelerated autoinfection and large
parasite load in the host. It often occurs in patients with
compromised immune systems.2 Patients with hyper-
infection syndrome often develop severe respiratory
distress and Gram-negative sepsis, which may be caused
by the migration of larvae from the gastrointestinal tract
to the pulmonary system. Here, we present 2 cases of
Strongyloides hyperinfection with the initial presentation
of acute dyspnea mimicking exacerbation of chronic
obstructive pulmonary disease (COPD), with severe
complications.
Case Reports
Case 1
An 88-year-old man presented in January 2007 with
exacerbated shortness of breath and dry cough. He was
a farmer with a history of COPD diagnosed 5 years
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previously. Combination therapy with inhaled long-
acting β-adrenergic agonist and inhaled steroids, and
oral theophylline were prescribed regularly at our out-
patient chest department. The most recent pulmonary
function test had revealed a positive bronchodilator
test, a post-bronchodilator FEV1/FVC ratio of 54%,
and a post-bronchodilator FEV1 of 1.24 L (72% of
predicted value). Oral prednisolone 10 mg daily for 
2 weeks was prescribed for acute exacerbation of COPD
at our outpatient department about 1 month before
this admission.
Due to increased sputum purulence and exacerbated
dyspnea, the patient visited our emergency department
and was admitted. Physical examination on admission
revealed a well-nourished male (body weight, 72 kg;
body height, 162 cm) with moderate respiratory dis-
tress, a temperature of 38.8°C, a pulse of 108 beats/
minute, and a respiratory rate of 26 breaths/minute.
Diffuse wheezing breath sounds were also noted. The
initial laboratory evaluation revealed hematocrit of
36.6%, white blood cell count of 7.3×103/mm3 (94.3%
neutrophils, 3% lymphocytes, 2.6% monocytes, 0.1%
eosinophils), and platelet count of 178 × 103/mm3.
Arterial blood gas analysis demonstrated a pH of 7.43,
PaCO2 of 34.4 mmHg, PaO2 of 72 mmHg, and bicar-
bonate of 23.1 mmol/L on room air. Chest radiogra-
phy on admission showed axial interstitial pattern of
bilateral lung fields (Figure 1). Medication on admis-
sion included intravenous steroids with hydrocortisone
300 mg daily, empiric antibiotic with augmentin, and
nebulized bronchodilators of β-adrenergic agonists
and anticholinergic agents.
The patient suffered acute respiratory failure with
desaturation several days after admission. Follow-up
chest radiography showed diffuse alveolar infiltration,
and acute respiratory distress syndrome (ARDS) was
considered from his serial data and clinical course.
Sputum examination and Gram stain were performed
after endotracheal intubation, which revealed several
rhabditiform larvae of S. stercoralis (Figure 2). A sub-
sequent stool examination was also positive for rhadi-
tiform larvae. The anthelmintic agent oral albendazole
400 mg daily was prescribed for Strongyloides hyperin-
fection. At this time, Escherichia coli and Klebsiella
pneumoniae were twice isolated from blood culture.
The empiric antibiotic was changed to ceftriaxone ac-
cording to a drug sensitivity test, but the patient died
2 days later due to disease progression and refractory
septic shock.
Case 2
A 76-year-old man presented in August 2004 with
exacerbated shortness of breath, poor appetite, and
abdominal distension. He was a retired soldier and
had a history of COPD that had been diagnosed over
10 years ago. The most recent pulmonary function
test showed a negative bronchodilator test, a post-
bronchodilator FEV1/FVC of 61%, and a post-bron-
chodilator FEV1 of 1.42 L (77% of predicted value).
Medication with inhaled bronchodilators and pred-
nisolone 20 mg daily for 2 weeks were prescribed at
our outpatient department before admission.
On review of systems, the patient denied diarrhea,
constipation, and abdominal pain, but said he had had
a poor appetite for a long time. Physical examination
on admission showed a poorly-nourished male (body
Figure 1. Case 1: posteroanterior radiography shows axial inter-
stitial pattern of bilateral lung fields.
Figure 2. Case 1: sputum examination and Gram stain show rhab-
ditiform larvae of Strongyloides stercoralis with few neutrophils
(original magnification, 100×).
weight, 38 kg; body height, 161 cm) with moderate
respiratory distress, temperature of 37.8°C, pulse of
134 beats/minute, and respiratory rate of 24 breaths/
minute. Diffuse wheezing breath sounds, hypoactive
bowel sounds and tympanic abdominal percussion were
noted. There was no focal tenderness or rebounding
pain on the abdomen. The initial laboratory evalua-
tion revealed hematocrit of 33.8%, white blood cell
count of 11.3 × 103/mm3 (93.1% neutrophils, 4.4%
lymphocytes, 2.3% monocytes, 0.1% eosinophils), and
platelet count of 240 × 103/mm3. The chemistry data
showed serum sodium of 124 mg/dL, potassium of
2.5 mg/dL, albumin of 2.7 mg/dL, and normal liver
function. Arterial blood gas analysis demonstrated pH
of 7.51, PaCO2 of 37.6 mmHg, PaO2 of 65 mmHg,
and bicarbonate of 30.6 mmol/L on room air. Chest
radiography showed diffuse axial interstitial pattern of
the lungs (Figure 3). Abdominal radiography revealed
ileus of the intestine. The medication on admission
included nebulized bronchodilators, empiric antibiotics
with ampicillin and sulbactam, and theophylline.
The patient developed respiratory failure 2 days after
admission and received intubation and mechanical ven-
tilation. Serial chest radiograph showed collapse of the
left lower lung, which was reopened the next day. The
initial sputum examination revealed many neutrophils
with few Gram-negative bacilli. One week after admis-
sion, the patient continued to suffer from intermittent
fever. A lumbar puncture was performed due to his
drowsy consciousness and neck stiffness. Examination
of cerebrospinal fluid revealed a white blood cell count
of 360/mm3 (66% neutrophils, 34% lymphocytes), glu-
cose of 45 mg/dL, protein of 220 mg/dL, and lactate
of 70 mg/dL. The empiric antibiotic was changed to
ceftriaxone under the suspicion of bacterial meningi-
tis. After that, repeated sputum examinations revealed
unexpected rhabditiform larvae of S. stercoralis, which
were also found in stool examinations. The fever sub-
sided gradually after anthelmintic treatment with alben-
dazole 400 mg daily. However, the fever recurred even
though he had received albendazole for 2 weeks. Sub-
sequent sputum and stool examinations did not reveal
any detectable larvae. At this time, his consciousness had
not improved and another lumbar puncture showed
no improvement in meningitis. Cultures and exami-
nations of cerebrospinal fluid revealed no bacteria and
no parasites. Nevertheless, his condition deteriorated
and he developed septic shock even after the antibiotic
was changed to piperacillin. He died 1 month after
admission.
Discussion
The ability to replicate in the human host permits
autoinfection of S. stercoralis leading to chronic infec-
tion. Chronic infection in patients can remain un-
detected for decades due to few or no symptoms.
However, hyperinfection syndrome can occur in immu-
nocompromised patients, and it has a high mortality
rate (up to 87%).2 The immunocompromised popula-
tion includes those undergoing steroid therapy or
chemotherapy, and those with hematologic malignancy,
kidney transplants, bone marrow transplants, human
T-lymphotropic virus type 1 infection, and hypogam-
maglobulinemia.3 The 2 cases presented here had both
been receiving systemic steroids for COPD control.
Case 1 was a farmer and so had a history of contact
with soil. Case 2 was emaciated (body mass index,
14.7 kg/m2) and had had abdominal symptoms for 
a long time prior to admission. We presume that they
had both been previously chronically infected with 
S. stercoralis but had subtle symptoms only. The trans-
formation of chronic infection to hyperinfection syn-
drome may have been caused by the steroid therapy
they had been prescribed from the outpatient depart-
ment. In Case 1, after admission, the intravenous
steroids prescribed for the symptoms that mimicked
COPD exacerbation may have worsened his hyper-
infection syndrome.
Complications of hyperinfection and disseminated
disease include bacterial and fungal infections, sepsis,
and meningitis. Secondary bacterial infection occurs
because of the leakage of gut flora from an ulcerative
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Figure 3. Case 2: posteroanterior radiography shows diffuse axial
interstitial pattern.
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bowel mucosa or as a result of bacteria carried on the
surface of the larvae when they migrate into the host’s
circulation. Therefore, blood cultures commonly grow
Escherichia coli, Klebsiella pneumoniae, Proteus mira-
bilis, Pseudomonas, and Enterococcus fecalis. Case 1 de-
veloped a typical manifestation of bacteremia caused by
Strongyloides hyperinfection. Case 2 ultimately devel-
oped septic shock without definite bacterial evidence;
however, he developed meningitis, which is the most
common central nervous system involvement of
Strongyloides hyperinfection. In patients with meningi-
tis associated with S. stercoralis, cerebrospinal fluid may
show parameters of aseptic meningitis,4 Gram-negative
bacterial meningitis,5 or parasitic meningitis.6 Our pa-
tient developed aseptic meningitis that was refractory
to treatment.
The pulmonary manifestation of Strongyloides hy-
perinfection may induce bronchospasms, cough, and
respiratory failure.7 It can mimic acute exacerbation of
underlying COPD or new-onset asthma.8,9 In addition,
blood counts in chronic infection often show eosin-
ophilia, but the condition of eosinophilia is often absent
in hyperinfection syndrome. In a study by Newberry
et al,7 3 of 7 patients with Strongyloides hyperinfection
died, and all of the fatal cases had eosinophil counts
< 400/mm3. Neither of our cases showed eosinophilia
during admission. Therefore, the absence of eosino-
philia in patients cannot exclude the diagnosis. With
regard to the chest imaging findings of Strongyloides
hyperinfection, pulmonary infiltration on chest radio-
graph has multiple patterns. It may present as diffuse
or focal interstitial infiltration, alveolar opacity, nodular
lesions, and even cavitation.10 Both of our cases pre-
sented with diffuse axial interstitial pattern on admis-
sion and Case 1 later progressed to ARDS.
The diagnosis of Strongyloides hyperinfection is not
difficult due to the high numbers of larvae that exist
in stool, sputum, and even body fluid. Except for stool
examinations, the larvae can be identified in sputum,
bronchoalveolar lavage fluid, bronchial brushings, lung
biopsies, or pleural fluid by microscopic examinations of
Gram, Papanicolaou, or acid-fast stains.3,8,10,11 Patients
in endemic areas with COPD or asthma receiving ste-
roids are at risk of hyperinfection syndrome. Therefore,
screening these high-risk patients is an important 
preventative measure. Although several immunodiag-
nostic assays have been developed for screening latent
Strongyloides infection, a highly specific and sensitive
diagnostic test is still lacking.2
In conclusion, the clinical manifestations of
Strongyloides hyperinfection are diverse. Besides show-
ing gastrointestinal symptoms, it may mimic acute ex-
acerbation of underlying COPD or new-onset asthma,
and be complicated with Gram-negative bacteremia and
meningitis. Therefore, stool and sputum examinations
are important when the clinical picture is suspicious
for Strongyloides hyperinfection, with or without eosin-
ophilia. We suggest that high-risk patients in endemic
areas should receive screening tests before receiving
immunosuppressant therapy.
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